EYPT
Price
$14.01
Change
+$2.13 (+17.93%)
Updated
Sep 5 closing price
Capitalization
965.67M
52 days until earnings call
NUVB
Price
$3.90
Change
+$0.48 (+14.04%)
Updated
Sep 5 closing price
Capitalization
1.33B
59 days until earnings call
Interact to see
Advertisement

EYPT vs NUVB

Header iconEYPT vs NUVB Comparison
Open Charts EYPT vs NUVBBanner chart's image
EyePoint Pharmaceuticals
Price$14.01
Change+$2.13 (+17.93%)
Volume$1.92M
Capitalization965.67M
Nuvation Bio
Price$3.90
Change+$0.48 (+14.04%)
Volume$22.01M
Capitalization1.33B
EYPT vs NUVB Comparison Chart in %
Loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EYPT vs. NUVB commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Buy and NUVB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (EYPT: $14.01 vs. NUVB: $3.90)
Brand notoriety: EYPT and NUVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 280% vs. NUVB: 413%
Market capitalization -- EYPT: $965.67M vs. NUVB: $1.33B
EYPT [@Biotechnology] is valued at $965.67M. NUVB’s [@Biotechnology] market capitalization is $1.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileNUVB’s FA Score has 0 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • NUVB’s FA Score: 0 green, 5 red.
According to our system of comparison, EYPT is a better buy in the long-term than NUVB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 4 TA indicator(s) are bullish while NUVB’s TA Score has 5 bullish TA indicator(s).

  • EYPT’s TA Score: 4 bullish, 4 bearish.
  • NUVB’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NUVB is a better buy in the short-term than EYPT.

Price Growth

EYPT (@Biotechnology) experienced а +21.09% price change this week, while NUVB (@Biotechnology) price change was +31.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

EYPT is expected to report earnings on Oct 29, 2025.

NUVB is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVB($1.34B) has a higher market cap than EYPT($966M). EYPT YTD gains are higher at: 88.054 vs. NUVB (46.617). EYPT has higher annual earnings (EBITDA): -172.05M vs. NUVB (-201.17M). NUVB has more cash in the bank: 608M vs. EYPT (256M). EYPT has less debt than NUVB: EYPT (21.8M) vs NUVB (57.8M). EYPT has higher revenues than NUVB: EYPT (51.9M) vs NUVB (14.4M).
EYPTNUVBEYPT / NUVB
Capitalization966M1.34B72%
EBITDA-172.05M-201.17M86%
Gain YTD88.05446.617189%
P/E RatioN/AN/A-
Revenue51.9M14.4M360%
Total Cash256M608M42%
Total Debt21.8M57.8M38%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EYPTNUVB
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 11 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYBCX63.891.07
+1.70%
Rydex Basic Materials C
KGIRX17.370.19
+1.11%
Kopernik International Investor
GACIX48.95N/A
N/A
Gabelli Small Cap Growth I
VSRAX24.88N/A
N/A
Invesco Small Cap Value R
RIVRX36.29-0.02
-0.06%
Riverbridge Growth Investor

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
+17.93%
OCUL - EYPT
65%
Loosely correlated
+7.09%
LYRA - EYPT
58%
Loosely correlated
-2.70%
ATHE - EYPT
54%
Loosely correlated
N/A
BEAM - EYPT
53%
Loosely correlated
+12.62%
RXRX - EYPT
52%
Loosely correlated
+1.99%
More

NUVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with XNCR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
+14.04%
XNCR - NUVB
49%
Loosely correlated
+2.15%
BEAM - NUVB
47%
Loosely correlated
+12.62%
RCUS - NUVB
47%
Loosely correlated
+5.45%
EYPT - NUVB
46%
Loosely correlated
+17.93%
DNLI - NUVB
46%
Loosely correlated
+4.33%
More